These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25061505)

  • 1. MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER.
    McDevitt VL; Mendez-Hinds J; Winwood D; Nijhawan V; Sherer T; Ritter JF; Sanberg PR
    Technol Innov; 2014 Nov; 16(1):75-84. PubMed ID: 25061505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act.
    Silva PJ; Ramos KS
    Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms.
    Sarpatwari A; Kesselheim AS; Cook-Deegan R
    J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
    Colaianni A; Cook-Deegan R
    Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-IP: staring down the Bayh-Dole Act with 2020 vision.
    Paradise J
    J Law Biosci; 2020; 7(1):lsaa073. PubMed ID: 33033619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 11. Academic research: policies and practice.
    Bertha SL
    J Ethnopharmacol; 1996 Apr; 51(1-3):59-73. PubMed ID: 9213631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who owns federally funded research? The Supreme court and the Bayh-Dole act.
    Kesselheim AS; Rajkumar R
    N Engl J Med; 2011 Sep; 365(13):1167-9. PubMed ID: 21879888
    [No Abstract]   [Full Text] [Related]  

  • 13. The Stakes in Bayh-Dole: Public Values Beyond the Pace of Innovation.
    Valdivia WD
    Minerva; 2011 Mar; 49(1):25-46. PubMed ID: 21475661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

  • 15. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayh-Dole: almost 25.
    Kennedy D
    Science; 2005 Mar; 307(5714):1375. PubMed ID: 15746390
    [No Abstract]   [Full Text] [Related]  

  • 17. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The valorization of non-patent intellectual property in academic medical centers.
    Marr K; Phan P
    J Technol Transf; 2020; 45(6):1823-1841. PubMed ID: 33012983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents and innovation in cancer therapeutics: lessons from CellPro.
    Bar-Shalom A; Cook-Deegan R
    Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaginaries of Invention Management: Comparing Path Dependencies in East and West Germany.
    Sigl L; Leišytė L
    Minerva; 2018; 56(3):357-380. PubMed ID: 30147147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.